PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $117,000 | +39.3% | 53,000 | +60.6% | 0.00% | – |
| Q1 2023 | $84,000 | +35.5% | 33,000 | 0.0% | 0.00% | – |
| Q4 2022 | $62,000 | -27.1% | 33,000 | 0.0% | 0.00% | – |
| Q3 2022 | $85,000 | +32.8% | 33,000 | 0.0% | 0.00% | – |
| Q2 2022 | $64,000 | -11.1% | 33,000 | +34.7% | 0.00% | – |
| Q1 2022 | $72,000 | -34.5% | 24,500 | 0.0% | 0.00% | – |
| Q4 2021 | $110,000 | -7.6% | 24,500 | 0.0% | 0.00% | – |
| Q3 2021 | $119,000 | -28.7% | 24,500 | 0.0% | 0.00% | – |
| Q2 2021 | $167,000 | +51.8% | 24,500 | +58.1% | 0.00% | – |
| Q1 2021 | $110,000 | +13.4% | 15,500 | 0.0% | 0.00% | – |
| Q4 2020 | $97,000 | +15.5% | 15,500 | -0.3% | 0.00% | – |
| Q3 2020 | $84,000 | +3.7% | 15,543 | 0.0% | 0.00% | – |
| Q2 2020 | $81,000 | +65.3% | 15,543 | 0.0% | 0.00% | – |
| Q1 2020 | $49,000 | – | 15,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 3,387,172 | $6,537,000 | 1.72% |
| Worth Venture Partners, LLC | 969,698 | $2,366,000 | 1.39% |
| Omega Fund Management, LLC | 1,971,241 | $3,804,000 | 1.21% |
| Telemetry Investments, L.L.C. | 495,000 | $955,000 | 1.13% |
| CM Management, LLC | 350,000 | $676,000 | 0.72% |
| Bruce & Co., Inc. | 1,557,312 | $3,005,000 | 0.71% |
| Trellus Management Company, LLC | 295,000 | $569,000 | 0.69% |
| Abingworth LLP | 1,041,131 | $1,999,000 | 0.64% |
| 1492 Capital Management LLC | 489,376 | $944,000 | 0.62% |
| GENERAL AMERICAN INVESTORS CO INC | 1,752,470 | $3,382,000 | 0.34% |